People with elevated amyloid levels in the brain but no signs of cognitive decline are indeed more likely to develop impairment down the road, potentially leading to full-on Alzheimer’s, according to a study published online June 12 in JAMA.  {read more here}

By providing basic educational materials on nuclear medicine and the potential risks from radiation exposure, clinicians can make patients feel more comfortable about their upcoming scans, according to a presentation on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting. {read more here}

Researchers at Emory University are reporting early success in fusing fluciclovine-PET and 3D ultrasound images to better detect and biopsy suspected recurrent prostate cancer. They presented their findings at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting. {read more here}

An estimated one in seven American men will be affected by prostate cancer in their lifetime. Prostate-specific molecular imaging gives these men a fighting chance, especially if their cancer returns, according to research revealed at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). {read more here}